The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Prophylaxis Strategies for Contrast-Induced Nephropathy
Abstract
CONTEXT: Contrast-induced nephropathy is associated with significant economic and clinical consequences, including prolonged hospitalization, the requirement for dialysis, and an increased risk of death. OBJECTIVES: To summarize the current state of evidence for prophylaxis of contrast-induced nephropathy, provide evidence-based recommendations regarding management of high-risk patients undergoing angiographic procedures, and identify new avenues for research. DATA SOURCES: Systematic searches of peer-reviewed publications were performed in MEDLINE, EMBASE, and the Cochrane database from 1966 to January 2006. Search terms included radio contrast nephropathy, contrast media, acetylcysteine, theophylline, sodium bicarbonate, HMG Co-A reductase inhibitors, ascorbic acid, kidney diseases, renal insufficiency, kidney failure, nephropathy, fenoldopam, diuretics, and saline or half saline. STUDY SELECTION: Observational studies of risk factors and randomized controlled trials of prophylaxis strategies for contrast-induced nephropathy that specified a definition of contrast-induced nephropathy or postprocedure creatinine level as an outcome measure. Evidence Synthesis Important patient-related risk factors for contrast-induced nephropathy include chronic kidney disease, diabetes mellitus, heart failure, older age, anemia, and left ventricular systolic dysfunction. Non-patient-related risk factors include high-osmolar contrast, ionic contrast, contrast viscosity, and contrast volume. Practice guidelines recommend obtaining preprocedural serum creatinine levels among patients with renal disease, diabetes, proteinuria, hypertension, gout, or congestive heart failure. Available evidence, largely based on small- to medium-sized trials, supports the use of hydration, bicarbonate, and low volumes of iso- or low-osmolar contrast in patients at risk. N-acetylcysteine or ascorbic acid may be of value in very high-risk patients. CONCLUSIONS: While several risk factors for contrast-induced nephropathy have been identified, the development of an effective prophylaxis strategy for contrast-induced nephropathy has been limited by our poor understanding of the pathophysiology and the clinical significance of this condition. Future research should focus on correctly identifying higher-risk patients and testing therapies in the setting of large well-powered clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hospital-acquired renal insufficiency
Nash, K., Hafeez, A., & Hou, S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32766 · Cited by 1,951
Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention
Rihal, C. S., Textor, S. C., Grill, D. E., Berger, P. B., Ting, H. H., Best, P. J., Singh, M., Bell, M. R., Barsness, G. W., Mathew, V., et al. (2002) · Circulation · doi:10.1161/01.cir.0000016043.87291.33 · Cited by 1,712
Acute Renal Failure After Coronary Intervention
McCullough, P. A., Wolyn, R., Rocher, L. L., Levin, R. N., & O’Neill, W. W. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00150-2 · Cited by 1,671
The effect of acute renal failure on mortality. A cohort analysis
Levy, E. M. (1996) · JAMA · doi:10.1001/jama.275.19.1489 · Cited by 1,660
Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine
Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430304 · Cited by 1,588
Solomon, R., Werner, C., Mann, D., D'Elia, J., & Silva, P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312104 · Cited by 1,254
MEHRAN, R., AYMONG, E., NIKOLSKY, E., LASIC, Z., IAKOVOU, I., FAHY, M., MINTZ, G., LANSKY, A., MOSES, J., & STONE, G. (2004) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(04)01445-7 · Cited by 1,251
Nephrotoxic Effects in High-Risk Patients Undergoing Angiography
Aspelin, P., Aubry, P., Fransson, S.-G., Strasser, R., Willenbrock, R., & Berg, K. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021833 · Cited by 1,136
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate: A Randomized Controlled Trial
Merten, G. J., Burgess, W. P., Gray, L. V., Holleman, J. H., Roush, T. S., Kowalchuk, G. J., Bersin, R. M., Van Moore, A., Simonton III, C. A., Rittase, R. A., et al. (2004) · JAMA · doi:10.1001/jama.291.19.2328 · Cited by 1,087
Parfrey, P. S., Griffiths, S. M., Barrett, B. J., Paul, M. D., Genge, M., Withers, J., Farid, N., & McManamon, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901193200303 · Cited by 1,011
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial
Rudnick, M. R., Goldfarb, S., Wexler, L., Ludbrook, P. A., Murphy, M. J., Halpern, E. F., Hill, J. A., Winniford, M., Cohen, M. B., VanFossen, D. B., et al. (1995) · Kidney International · doi:10.1038/ki.1995.32 · Cited by 923
Mueller, C., Buerkle, G., Buettner, H. J., Petersen, J., Perruchoud, A. P., Eriksson, U., Marsch, S., & Roskamm, H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.329 · Cited by 806
Gruberg, L., Mintz, G. S., Mehran, R., Dangas, G., Lansky, A. J., Kent, K. M., Pichard, A. D., Satler, L. F., & Leon, M. B. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00917-7 · Cited by 749
Marenzi, G., Lauri, G., Assanelli, E., Campodonico, J., De Metrio, M., Marana, I., Grazi, M., Veglia, F., & Bartorelli, A. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.043 · Cited by 737
Best, P. J. M., Lennon, R., Ting, H. H., Bell, M. R., Rihal, C. S., Holmes, D. R., & Berger, P. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01745-x · Cited by 731
Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.
Barrett, B. J., & Carlisle, E. J. (1993) · Radiology · doi:10.1148/radiology.188.1.8511292 · Cited by 727
Shlipak, M. G., Heidenreich, P. A., Noguchi, H., Chertow, G. M., Browner, W. S., & McClellan, M. B. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00006 · Cited by 559
Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification
Bartholomew, B. A., Harjai, K. J., Dukkipati, S., Boura, J. A., Yerkey, M. W., Glazier, S., Grines, C. L., & O'Neill, W. W. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.008 · Cited by 524
The Prevention of Radiocontrast-Agent–Induced Nephropathy by Hemofiltration
Marenzi, G., Marana, I., Lauri, G., Assanelli, E., Grazi, M., Campodonico, J., Trabattoni, D., Fabbiocchi, F., Montorsi, P., & Bartorelli, A. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023204 · Cited by 504
Acetylcysteine for prevention of contrast nephropathy: meta-analysis
Birck, R., Krzossok, S., Markowetz, F., Schnülle, P., van der Woude, F. J., & Braun, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14189-x · Cited by 477
Trivedi, H. S., Moore, H., Nasr, S., Aggarwal, K., Agrawal, A., Goel, P., & Hewett, J. (2004) · Nephron Clinical Practice · doi:10.1159/000066641 · Cited by 446
Gleeson, T. G., & Bulugahapitiya, S. (2004) · American Journal of Roentgenology · doi:10.2214/ajr.183.6.01831673 · Cited by 441
Kay, J., Chow, W. H., Chan, T. M., Lo, S. K., Kwok, O. H., Yip, A., Fan, K., Lee, C. H., & Lam, W. F. (2003) · JAMA · doi:10.1001/jama.289.5.553 · Cited by 434
Stone, G. W., McCullough, P. A., Tumlin, J. A., Lepor, N. E., Madyoon, H., Murray, P., Wang, A., Chu, A. A., Schaer, G. L., Stevens, M., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2284 · Cited by 412
Schwab, S. J., Hlatky, M. A., Pieper, K. S., Davidson, C. J., Morris, K. G., Skelton, T. N., & Bashore, T. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901193200304 · Cited by 404
Acetylcysteine and contrast agent-associated nephrotoxicity
Briguori, C., Manganelli, F., Scarpato, P., Elia, P. P., Golia, B., Riviezzo, G., Lepore, S., Librera, M., Villari, B., Colombo, A., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01958-7 · Cited by 360
Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial)
Diaz-Sandoval, L. J., Kosowsky, B. D., & Losordo, D. W. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02243-3 · Cited by 350
Alonso, A., Lau, J., Jaber, B. L., Weintraub, A., & Sarnak, M. J. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.09.009 · Cited by 345
A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study
Baker, C. S. R., Wragg, A., Kumar, S., De Palma, R., Baker, L. R. I., & Knight, C. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00487-x · Cited by 340
Spargias, K., Alexopoulos, E., Kyrzopoulos, S., Iacovis, P., Greenwood, D. C., Manginas, A., Voudris, V., Pavlides, G., Buller, C. E., Kremastinos, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000146396.19081.73 · Cited by 317
Durham, J. D., Caputo, C., Dokko, J., Zaharakis, T., Pahlavan, M., Keltz, J., Dutka, P., Marzo, K., Maesaka, J. K., & Fishbane, S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00673.x · Cited by 300
Vogt, B., Ferrari, P., Schönholzer, C., Marti, H.-P., Mohaupt, M., Wiederkehr, M., Cereghetti, C., Serra, A., Huynh-Do, U., Uehlinger, D., et al. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00983-4 · Cited by 290
Shyu, K.-G. I., Cheng, J.-J., & Kuan, P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02308-2 · Cited by 288
Systematic review of the impact of N-acetylcysteine on contrast nephropathy
Pannu, N., Manns, B., Lee, H., & Tonelli, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00516.x · Cited by 284
Self-citationAllaqaband, S., Tumuluri, R., Malik, A. M., Gupta, A., Volkert, P., Shalev, Y., & Bajwa, T. K. (2002) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.10323 · Cited by 260
Acute renal failure requiring dialysis after percutaneous coronary interventions
Gruberg, L., Mehran, R., Dangas, G., Mintz, G. S., Waksman, R., Kent, K. M., Pichard, A. D., Satler, L. F., Wu, H., & Leon, M. B. (2001) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.1093 · Cited by 250
Davidson, C. J., Hlatky, M., Morris, K. G., Pieper, K., Skelton, T. N., Schwab, S. J., & Bashore, T. M. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-2-119 · Cited by 249
Kshirsagar, A. V., Poole, C., Mottl, A., Shoham, D., Franceschini, N., Tudor, G., Agrawal, M., Denu-Ciocca, C., Magnus Ohman, E., & Finn, W. F. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000116241.47678.49 · Cited by 238
Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity
Briguori, C. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.11.016 · Cited by 236
Contrast nephropathy: Review focusing on prevention
Maeder, M., Klein, M., Fehr, T., & Rickli, H. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.075 · Cited by 227
Abizaid, A. S., Clark, C. E., Mintz, G. S., Dosa, S., Popma, J. J., Pichard, A. D., Satler, L. F., Harvey, M., Kent, K. M., & Leon, M. B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00833-9 · Cited by 224
PREPARED: PREParation for Angiography in REnal Dysfunction
Taylor, A. J., Hotchkiss, D., Morse, R. W., & McCabe, J. (1998) · Chest · doi:10.1378/chest.114.6.1570 · Cited by 218
Solomon, R. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00684.x · Cited by 209
Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial.
Moore, R. D., Steinberg, E. P., Powe, N. R., Brinker, J. A., Fishman, E. K., Graziano, S., & Gopalan, R. (1992) · Radiology · doi:10.1148/radiology.182.3.1535876 · Cited by 204
Marenzi, G., Lauri, G., Campodonico, J., Marana, I., Assanelli, E., De Metrio, M., Grazi, M., Veglia, F., Fabbiocchi, F., Montorsi, P., et al. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.08.002 · Cited by 191
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure.
Russo, D., Minutolo, R., Cianciaruso, B., Memoli, B., Conte, G., & De Nicola, L. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v651451 · Cited by 189
Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis
Nallamothu, B. K., Shojania, K. G., Saint, S., Hofer, T. P., Humes, H. D., Moscucci, M., & Bates, E. R. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.06.046 · Cited by 188
McCullough, P. A., & Soman, S. S. (2005) · Critical Care Clinics · doi:10.1016/j.ccc.2004.12.003 · Cited by 180
Webb, J. G., Pate, G. E., Humphries, K. H., Buller, C. E., Shalansky, S., Al Shamari, A., Sutander, A., Williams, T., Fox, R. S., & Levin, A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.041 · Cited by 176
Goldenberg, I. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.11.011 · Cited by 160
Arstall, M. A., Yang, J., Stafford, I., Betts, W. H., & Horowitz, J. D. (1995) · Circulation · doi:10.1161/01.cir.92.10.2855 · Cited by 155
Acetylcysteine and Nephrotoxic Effects of Radiographic Contrast Agents — A New Use for an Old Drug
Safirstein, R. L., Andrade, L., & Vieira, J. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430311 · Cited by 151
N-Acetylcysteine and contrast-induced nephropathy: A meta-analysis of 13 randomized trials
Zagler, A., Azadpour, M., Mercado, C., & Hennekens, C. H. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.01.055 · Cited by 145
Theophylline for Prevention of Contrast-Induced Nephropathy
Bagshaw, S. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1087 · Cited by 137
Isenbarger, D. W., Kent, S. M., & O’Malley, P. G. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.08.059 · Cited by 126
N-acetylcysteine for the prevention of contrast-induced nephropathy
Liu, R., Nair, D., Ix, J. H., Moore, D. H., & Bent, S. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.30323.x · Cited by 120
Bagshaw, S. M., & Ghali, W. A. (2004) · BMC Medicine · doi:10.1186/1741-7015-2-38 · Cited by 119
Duong, M. H., MacKenzie, T. A., & Malenka, D. J. (2005) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.20342 · Cited by 110
Efrati, S., Dishy, V., Averbukh, M., Blatt, A., Krakover, R., Weissgarten, J., Morrow, J. D., Stein, M. C., & Golik, A. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00322.x · Cited by 107
Fung, J. W., Szeto, C., Chan, W. W. M., Kum, L. C. C., Chan, A. K.-Y., Wong, J. T. H., Wu, E. B., Yip, G. W., Chan, J. Y., Yu, C., et al. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.01.010 · Cited by 96
Frank, H., Werner, D., Lorusso, V., Klinghammer, L., Daniel, W. G., Kunzendorf, U., & Ludwig, J. (2003) · Clinical Nephrology · doi:10.5414/cnp60176 · Cited by 90
Misra, D., Leibowitz, K., Gowda, R. M., Shapiro, M. D., & Khan, I. A. (2004) · Clinical Cardiology · doi:10.1002/clc.4960271106 · Cited by 86
Nikolsky, E., Aymong, E. D., Dangas, G., & Mehran, R. (2003) · PubMed · Cited by 72
Brunet, J., Boily, M.-J., Cordeau, S., & Rosiers, C. D. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00077-b · Cited by 62
The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy
Guru, V., & Fremes, S. E. (2004) · Clinical Nephrology · doi:10.5414/cnp62077 · Cited by 49
Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN)
Ng, T. M. H., Shurmur, S. W., Silver, M., Nissen, L. R., O’Leary, E. L., Rigmaiden, R. S., Cieciorka, M., Porter, L. L., Ineck, B. A., Kline, M. E., et al. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.06.038 · Cited by 44
Klarenbach, S. W., Pannu, N., Tonelli, M. A., & Manns, B. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000206287.22318.c3 · Cited by 37
Self-citation
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Authors/Task Force Members, Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr236 · Cited by 3,080
Chaikof, E. L., Dalman, R. L., Eskandari, M. K., Jackson, B. M., Lee, W. A., Mansour, M. A., Mastracci, T. M., Mell, M., Murad, M. H., Nguyen, L. L., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.10.044 · Cited by 2,751
Authors/Task Force Members, Bassand, J.-P., Hamm, C. W., Ardissino, D., Boersma, E., Budaj, A., Fernandez-Aviles, F., Fox, K. A. A., Hasdai, D., Ohman, E. M., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm161 · Cited by 1,849
Contrast Medium-Induced Acute Kidney Injury
Sadat, U., Usman, A., Boyle, J. R., Hayes, P. D., & Solomon, R. J. (2015) · Cardiorenal Medicine · doi:10.1159/000430770 · Cited by 1,285
Metadata
- Authors
- Pannu, N., Wiebe, N., Tonelli, M., & Alberta Kidney Disease Network, F. T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-06-21
- Volume
- 295
- Issue
- 23
- Pages
- 2765
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2155250786
- Cited by
- 410
- References
- 67
- FWCI
- 23.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.